Ascentage Pharma Group International Share Price

NASDAQ: AAPG

Small Cap

$39.21

+0.58

(+1.50%)

as on September 17, 2025 at 12:34 am IST

$₹

Ascentage Pharma Group International Stock Performance

as on September 17, 2025 at 12:34 am IST

Day's Low
$39
Day's Price Range
$39.21
$39.21
0.54%
Downside
52 Week's Low
52 Week's High
$17
52-Week Price Range
$48.45
$39.21
56.64%
Downside
23.57%
Upside

Ascentage Pharma Group International share price movements today

Previous Close: $38.63
Open: $39.09
Volume: 122.1K
Day's Low - High: $39 - $39.21
52 Week Low - High: $17 - $48.45

Ascentage Pharma Group International Historical Returns

1 Month Return: -12.86 %
3 Month Return: + 23.93 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Ascentage Pharma Group International Stock Fundamentals & Key Indicators

Check Ascentage Pharma Group International market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.4B

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

37535700.00%

Ascentage Pharma Group International vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ascentage Pharma Group International with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Ascentage Pharma Group International	NA	$6.4B	NA	NA	-39.90%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	252.04%	-505.15	-12.96%
Beone Medicines Ltd	NA	$39.0B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$100.3B	44.17%	27.85	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	1.78%	14.1	31.37%

Ascentage Pharma Group International Stock's Interest Amongst Investors

Search interest for Ascentage Pharma Group International Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:33% versus previous 30 day period

Ascentage Pharma Group International Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2017	Mar 2018	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025
Total Revenue	0	0	39	39	411	411	78	78
Gross Profit	0	0	33	33	404	404	71	71
Operating Income	-2	-7	-266	-266	93	93	-283	-283
EBITDA	-1	0	-246	-246	114	114	-264	-264
Interest Expense	1	2	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-3	-2	-266	-266	81	81	-279	-279
Income Tax Expense	0	0	-4	-4	0	0	5	5
Net Income	-3	-2	-261	-261	81	81	-284	-284
Net Profit Margin	-1286.13%	-1423.39%	-660.01%	-660.01%	19.79%	19.79%	-362.28%	-362.28%

Ascentage Pharma Group International Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	7	6	6	14	12	4	209	221	134
Gross Profit	7	6	6	12	10	24	187	191	130
Operating Income	-114	-130	-50	-582	-663	-869	-849	-872	-369
EBITDA	-103	-49	-291	-1,451	-641	-787	-771	-743	-237
Interest Expense	3	57	36	4	6	16	52	96	64
Depreciation	-	-	-	-	27	28	62	93	93
Income Before Tax	-107	-120	-346	-1,482	-675	-832	-887	-932	-395
Income Tax Expense	-	-1	-1	-1	2	-49	-4	-7	10
Net Income	-107	-118	-345	-1,480	-677	-782	-882	-925	-55
Net Profit Margin	-1406.53%	-1872.85%	-5072.82%	-10202.67%	-5442.62%	-18080.02%	-421.02%	-416.98%	-41.34%

Ascentage Pharma Group International Quarterly Cash Flow

All numbers in Millions USD

	Mar 2018	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025
Net Income	-58	-261	-261	81	81	-284	-284
Operating Cash Flow	-58	-178	-178	-177	-177	121	121
Investing Cash Flow	28	43	43	-65	-65	-115	-115
Financing Cash Flow	33	-43	-43	198	198	-41	-41
Change in Cash	-	-1,389	-	-	-	-	-

Ascentage Pharma Group International Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-120	-346	-1,482	-675	-832	-887	-932	-395
Operating Cash Flow	-107	-237	-460	-609	-604	-653	-726	-111
Investing Cash Flow	-230	292	-201	-107	-466	-384	21	-362
Financing Cash Flow	58	860	442	1,040	1,781	619	368	314
Change in Cash	-279	942	-218	280	686	-361	-307	-144

Insights on Ascentage Pharma Group International

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 1 month, AAPG stock has moved down by -12.9%

About Ascentage Pharma Group International

Ascentage Pharma Group International is a holding company primarily engaged in discovering, developing and commercializing therapies primarily in hematological malignancies. The Company’s main business is engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus and certain age-related diseases. The Company’s main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918 and other products. The Company’s products are mainly used to address the major hematological malignancies, including chronic myeloid leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, acute lymphocytic leukemia, myelodysplastic syndrome, and multiple myeloma. The Company mainly conducts its business in the domestic market.

Organisation	Ascentage Pharma Group International
Headquarters	Suzhou Industrial Park, Suzhou, China, 215000
CEO	Dr. Dajun Yang M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Ascentage Pharma Group International

Name	Title
Dr. Veet Misra	Chief Financial Officer
Dr. Yifan Zhai M.D., Ph.D.	Chief Medical Officer
Mr. Raymond Jeffrey Kmetz	Chief Business Officer
Mr. Jin Cao	Head of Finance
Mr. Eric Huang	Senior Vice President of Global Corporate Development & Finance
Dr. Dajun Yang M.D., Ph.D.	Co-Founder, Chairman & CEO
Dr. Shaomeng Wang Ph.D.	Co-Founder, Chief Scientific Advisor & Non-Executive Director
Dr. Ming Guo	Co-Founder
Mr. Thomas Joseph Knapp J.D.	Senior VP & General Counsel
Dr. Chongdong Fu	Senior VP & Head of CMC

FAQs

What is Ascentage Pharma Group International share price today?

Ascentage Pharma Group International share price today is $39.21 as on September 17, 2025 at 12:34 am IST at the close of the market. Ascentage Pharma Group International share today touched a day high of $39.21 and a low of $39.

What is the 52 week high and 52 week low for Ascentage Pharma Group International share?

Ascentage Pharma Group International share touched a 52 week high of $48.45 on August 22, 2025 and a 52 week low of $17 on January 27, 2025. Ascentage Pharma Group International stock price today i.e. September 17, 2025 at 12:34 am IST is closed at $39.21,which is 19.07% down from its 52 week high and 130.65% up from its 52 week low.

What is Ascentage Pharma Group International's market capitalisation today?

Ascentage Pharma Group International market capitalisation is $0.01T as on September 17, 2025 at 12:34 am IST.

How to invest in Ascentage Pharma Group International Stock (AAPG) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Ascentage Pharma Group International on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ascentage Pharma Group International Shares that will get you 0.0383 shares as per Ascentage Pharma Group International share price of $39.21 per share as on September 17, 2025 at 12:34 am IST.

What is the minimum amount required to buy Ascentage Pharma Group International Stock (AAPG) from India?

Indian investors can start investing in Ascentage Pharma Group International (AAPG) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 3:46 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Ascentage Pharma Group International stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 3:46 pm IST). Based on Ascentage Pharma Group International share’s latest price of $39.21 as on September 17, 2025 at 12:34 am IST, you will get 0.2550 shares of Ascentage Pharma Group International. Learn more about fractional shares .